Home › Funds › Stephens Investment Management Group LLC › LGND

Stephens Investment Management Group LLC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

Stephens Investment Management Group LLC reported holding 446,140 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$139.4M, representing 1.50% of its reported portfolio and ranking #7 among its reported holdings. Stephens Investment Management Group LLC has disclosed LGND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)446.14K sh
Reported value held$139.36M
Portfolio Weight1.50%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Stephens Investment Management Group LLC's LGND position evolved

Stephens Investment Management Group LLC first disclosed a stake in LGND in Q3 2023 at 467,564 shares (US$28.0M). The position peaked in Q2 2026 at 475,609 shares, worth US$150.3M. Across 13 filings, Stephens Investment Management Group LLC increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 446,140 shares valued at US$139.4M — a reduction of -29,469 shares quarter over quarter.. Notable position changes include a 41% increase in Q4 2023 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 467.56K $28.02M New
Q4 2023 659.43K $47.10M Add
Q1 2024 696.76K $50.93M Add
Q2 2024 652.00K $54.94M Reduce
Q3 2024 618.70K $61.93M Reduce
Q4 2024 612.78K $65.66M Reduce
Q1 2025 607.22K $63.84M Reduce
Q2 2025 604.81K $68.76M Hold
Q3 2025 554.54K $98.23M Reduce
Q4 2025 501.04K $94.73M Reduce
Q1 2026 494.67K $98.76M Reduce
Q2 2026 475.61K $150.34M Reduce
Q3 2026 446.14K $139.36M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 51 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), RICE HALL JAMES & ASSOCIATES, LLC (US$85.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has Stephens Investment Management Group LLC held LGND?

Stephens Investment Management Group LLC has disclosed LGND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Stephens Investment Management Group LLC's current position in LGND?

As of Q3 2026, Stephens Investment Management Group LLC holds 446.14K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $139.36M, representing 1.50% of its reported portfolio and ranking #7.

Has Stephens Investment Management Group LLC been buying or selling LGND?

In the latest 13F filing (Q3 2026), Stephens Investment Management Group LLC reduced its position in LGND. The position peaked in Q2 2026 at 475.61K shares.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, RICE HALL JAMES & ASSOCIATES, LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.